SCHEMBL25938044

SCHEMBL25938044

C=CCCC(C(=C)NC)N(C)Cc1cc(N(CCNC)C2CCCCC2)ccc1C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25989012 0.79 SMN1; SMN2 (0.32) —
SCHEMBL25939038 0.78 PTGS1 (0.31) —
SCHEMBL25992129 0.78 SMN1; SMN2 (0.31) —
SCHEMBL25994537 0.77 ACACB (0.31) —
SCHEMBL25937870 0.75 — —
SCHEMBL25937913 0.75 PRKCI (0.31) —
SCHEMBL25937604 0.75 — —
SCHEMBL27111632 0.75 SLC6A2 (0.32) —
SCHEMBL20194368 0.75 — —
SCHEMBL25986754 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820574-B1 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2023-08-09 — — EP disclosed
Send feedback